This article is a correction to:
Defining Discriminatory Antibody Fingerprints in Active and Latent Tuberculosis
Nadege Nziza1†
Deniz Cizmeci1†
Leela Davies1,2Edward B. Irvine1,3
Wonyeong Jung1Brooke A. Fenderson1Marwou de Kock4
Willem A. Hanekom5,6
Kees L. M. C. Franken7
Cheryl L. Day8*
Tom H. M. Ottenhoff7*Galit Alter1*- 1Ragon Institute of Massachusetts General Hospital (MGH), Massachusetts Institute of Technology (MIT) and Harvard, Cambridge, MA, United States
- 2Division of Infectious Diseases, Brigham and Women’s Hospital, Boston, MA, United States
- 3Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, United States
- 4South African Tuberculosis Vaccine Initiative (SATVI) and School of Child and Adolescent Health, Institute of Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa
- 5Africa Health Research Institute, Durban, South Africa
- 6Division of Infection and Immunity, University College London, London, United Kingdom
- 7Department of Infectious Disease, Leiden University, Leiden, Netherlands
- 8Department of Microbiology and Immunology, Emory University School of Medicine, Emory University, Atlanta, GA, United States
A Corrigendum on
Defining discriminatory antibody fingerprints in active and latent tuberculosis
by Nziza N, Cizmeci D, Davies L, Irvine EB, Jung W, Fenderson BA, de Kock M, Hanekom WA, Franken KLMC, Day CL, Ottenhoff THM and Alter G (2022) Front. Immunol. 13:856906. doi: 10.3389/fimmu.2022.856906
In the published article, there was an error in Supplemental Table 1 as published. An incorrect antigen was added to the list: Rv1926. The corrected Supplemental Table 1, without Rv1926 and its caption “List of Mtb proteins” are attached.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: active and latent tuberculosis, antibodies, HIV, biomarkers, diagnostics
Citation: Nziza N, Cizmeci D, Davies L, Irvine EB, Jung W, Fenderson BA, de Kock M, Hanekom WA, Franken KLMC, Day CL, Ottenhoff THM and Alter G (2023) Corrigendum: Defining discriminatory antibody fingerprints in active and latent tuberculosis. Front. Immunol. 14:1329784. doi: 10.3389/fimmu.2023.1329784
Received: 29 October 2023; Accepted: 09 November 2023;
Published: 21 November 2023.
Edited and Reviewed by:
Ian Marriott, University of North Carolina at Charlotte, United StatesCopyright © 2023 Nziza, Cizmeci, Davies, Irvine, Jung, Fenderson, de Kock, Hanekom, Franken, Day, Ottenhoff and Alter. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Galit Alter, galter@partners.org; Tom H. M. Ottenhoff, T.H.M.Ottenhoff@lumc.nl; Cheryl L. Day, cheryl.day@emory.edu
†These authors have contributed equally to this work and share first authorship